Tirzepatide (Zepbound) is a dual incretin therapy that activates GLP-1 and GIP receptors to promote significant weight loss. It outperforms older drugs like semaglutide, with users losing over 20% of body weight on average. Learn how it works, its side effects, and who it’s right for.
Learn More